Patients with hematologic cancer and their caregivers are at risk of financial toxicity, especially in the bone marrow transplantation setting.
A secondary analysis of supportive care trial data demonstrated that an approach-oriented coping strategy improved QOL and psychological distress in patients with hematologic cancer undergoing HCT.
Survival outcomes have improved for younger patients with multiple myeloma, especially among those who underwent auto-HSCT after 2010.
Results of the Breast Cancer Weight Loss trial were presented at the 2023 ASCO Annual Meeting.
A review of the literature identified interventions that may increase understanding and uptake of genetic testing for BRCA1/2 variants.
A project designed to improve the interaction within a multidisciplinary team on a HSCT unit was presented at the 48th Annual ONS Congress.
A nurse-led team developed a tool to assess patients with sarcoma undergoing multiday ifosfamide regimens for early signs of neurotoxicity.
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
The unique needs of patients with AML undergoing maintenance therapy, including care disparities and challenges, are discussed at the 2023 ONA Summit.
A follow-up study assessed long-term effects of endocrine therapy in breast cancer survivors who reported endocrine therapy-related effects in a previous study.
